Log In
BCIQ
Print this Print this
 

Thetanix

  Manage Alerts
Collapse Summary General Information
Company 4D Pharma plc
DescriptionCapsules of live Bacteroides thetaiotaomicron isolated from the gut of healthy individuals
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease (CD)
Regulatory Designation U.S. - Orphan Drug (Treat Crohn's disease (CD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2.1M

$2.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/03/2014

$2.1M

$2.1M

0

Get a free BioCentury trial today